Anti-SGF29 antibody - N-terminal
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Polyclonal SGF29 antibody. N-terminal. Suitable for IHC-P, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human SGF29 aa 1-100.
View Alternative Names
CCDC101, SGF29, SAGA-associated factor 29, Coiled-coil domain-containing protein 101, SAGA complex-associated factor 29
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SGF29 antibody - N-terminal (AB204367)
Immunohistochemical analysis of paraffin-embedded Human testis tissue labeling SGF29 with ab204367 at 1/200 dilution.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-SGF29 antibody - N-terminal (AB204367)
Immunofluorescence analysis of MCF7 cells labeling SGF29 with ab204367 at 4 μg/ml.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The role of SGF29 involves it in chromatin remodeling and transcriptional activation processes. It acts as a scaffold protein binding to methylated histone H3 lysine residues and helps localize the SAGA complex to chromatin sites that are marked for transcription. By attaching to these regions SGF29 facilitates the acetylation of histones a modification that leads to the relaxation of chromatin structure more accessible to transcription machinery.
Pathways
Researchers describe SGF29 as part of the transcriptional regulation pathway and epigenetic modification processes. SGF29 is especially significant in pathways involving the acetylation of histones through the SAGA complex. It works closely with other proteins such as GCN5 and ADA2 which are also components of the SAGA complex. SGF29's interaction with these proteins ensures that acetylation proceeds efficiently influencing gene expression patterns.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Clinical and translational medicine 12:e719 PubMed35092699
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com